Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sabol BJ et al. – A 42–year–old man with a history of recurrent thromboembolisms demonstrated resistance to oral warfarin therapy due to warfarin malabsorption.

Related Articles

Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
Chest, 10/08/09    Relevance Score: 89%

Prevention of Venous Thromboembolism in Thoracic and Cardiovascular Surgery
Asian Cardiovascular and Thoracic Annals, 11/20/09    Relevance Score: 88%

Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials
Circulation, 11/04/09    Relevance Score: 87%

Hematocrit and risk of venous thromboembolism in a general population. The Tromso Study
Haematologica, 10/21/09    Relevance Score: 87%

2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group
Critical Reviews in Oncology/Hematology, 10/07/09    Relevance Score: 87%

Today in Drug Resistance...keeping you current

Two antimalaria drugs are tolerated regimens in regions with resistance
Formulary , 12/02/09

Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09

Environmental-mediated drug resistance: a target for multiple myeloma therapy
Expert Review of Hematology, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address